Resmed Inc

Resmed Inc

RMD - NEW YORK STOCK EXCHANGE, INC.

Industry: Health Care

Market Cap: 35.9 B

IPO Date: Jun 1, 1995

Country: US

Currency: USD

Shares Outstanding: 146.6 M

Invesco Oppenheimer International Growth Fund Q1 2025 Commentary

5/11/2025

During the quarter, apparent uncertainty about US industrial, tax and trade policy appeared to dampen equity market performance, particularly in the US. Read more here.

News

Source: SeekingAlpha

ResMed Inc. stock rises Wednesday, outperforms market

5/7/2025

ResMed Inc. stock rises Wednesday, outperforms market

News

Source: MarketWatch

3 Profitable Stocks to Consider Right Now

5/6/2025

Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting themselves up for long-term success.

News

Source: Yahoo

Top 50 High-Quality Dividend Stocks For May 2025

5/3/2025

Discover top dividend growth stocks with strong returns and attractive valuations. See which 17 stocks had rating changes this month.

News

Source: SeekingAlpha

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

5/3/2025

Readers hoping to buy ResMed Inc. ( NYSE:RMD ) for its dividend will need to make their move shortly, as the stock is...

News

Source: Yahoo

ResMed Inc. stock rises Friday, still underperforms market

5/2/2025

ResMed Inc. stock rises Friday, still underperforms market

News

Source: MarketWatch

This ResMed Insider Reduced Their Stake By 72%

5/2/2025

From what we can see, insiders were net sellers in ResMed Inc.'s ( NYSE:RMD ) during the past 12 months. That is...

News

Source: Yahoo

Top 15 High-Growth Dividend Stocks To Consider For May 2025

5/2/2025

Discover May 2025's Top 15 High-Growth Dividend Stocks with a 1.33% yield, 21.25% growth rate, and 29% undervaluation.

News

Source: SeekingAlpha

Resmed acquires independent diagnostic testing facility VirtuOx

5/2/2025

The deal is set to enhance Resmed's ability to collaborate with healthcare providers to improve the diagnostic process.

News

Source: Yahoo

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

5/2/2025

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience hired an executive to support its BCI commercialization plans.

News

Source: Yahoo

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

5/1/2025

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

News

Source: Yahoo

Resmed Acquires VirtuOx

5/1/2025

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providersSAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s co

News

Source: Yahoo

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

4/30/2025

We recently published a list of Jim Cramer Says The Day “Everything’s A Lot More Expensive” Is Coming & Discusses These 10 Stocks. In this article, we are going to take a look at where Resmed Inc (NYSE:RMD) stands against other stocks that Jim Cramer recently discussed. In his appearance on CNBC’s Squawk on the […]

News

Source: Yahoo

iRhythm Earnings: What To Look For From IRTC

4/30/2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results tomorrow afternoon. Here’s what investors should know.

News

Source: Yahoo

ResMed Inc. stock rises Tuesday, outperforms market

4/29/2025

ResMed Inc. stock rises Tuesday, outperforms market

News

Source: MarketWatch

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

4/26/2025

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with analysts’ consensus estimates.

News

Source: Yahoo

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

4/25/2025

Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.

News

Source: Yahoo

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

4/25/2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

News

Source: Yahoo

ResMed : Earnings Webcast Q3 2025 Transcript PDF

4/25/2025

REFINITIV STREETEVENTS EDITED TRANSCRIPT RMD.N - Q3 2025 Resmed Inc Earnings Call EVENT DATE/TIME: APRIL 23, 2025 / 8:30PM GMT ...

News

Source: Finnhub